Sprague-Dawley rats were given 42 mg/kg xylazine intramuscularly, and lungs were lavaged with phosphate-buffered saline 3, 6, and 12 hr later. Total protein, lactate dehydrogenase (LDH), xanthine oxidase (XO), tumor necrosis factor (TNF), and interleukin 1 (IL-1) were measured in bronchoalveolar lavage fluid (BALF). Protein concentration, LDH, XO, and TNF levels were increased (p < 0.05) in the BALF from xylazine-treated rats as compared to controls. IL-1 level was unchanged at 3 and 6 hr and was reduced (p < 0.05) at 12 hr. Another group of rats was given 42 mg/kg xylazine intramuscularly, and lungs were fixed 0.5 and 12 hr later. Histologically, severe pulmonary edema (PE) involving the alveoli and perivascular stroma was observed. Fibrin, increased numbers of eosinophils, and macrophages with foamy cytoplasm were present in the alveoli of all treated animals. Ultrastructurally, endothelial damage, characterized by thinning, detachment from basement membranes, or bleb formation, was observed. The lesions were similar in both xylazine groups, differing mainly in severity with the 12-hr group having more severe lesions than the 0.5-hr group. To determine whether endothelial injury is caused by direct toxicity of xylazine, bovine pulmonary artery endothelial cells (BPAECs) were incubated with xylazine (0.3, 3, and 30 μg) for 0.5 or 3 hr. Xylazine did not have any effects on BPAECs, as indicated by phase-contrast microscopy and dye-exclusion viability assay. These results indicate that xylazine-induced PE is due to increased permeability resulting from endothelial injury, which is not caused by direct effect of xylazine on pulmonary endothelium. While oxygen radicals and TNF are possibly involved, IL-1 does not appear to play a role in xylazine-induced PE.
Aderka D., Fisher S., Levo Y., Holtman, Hahn T., and Wallace D. (1985). Cachectin/tumor-necrosis-factor production by cancer patients. Lancet2: 1190.
2.
Amouzadeh HR , Sangiah S., Qualls CW Jr, Cowell RL, and Mauromoustakos A. (1991). Xylazine-induced pulmonary edema in rats. Toxicol. Appl. Pharmacol . 108: 417-427.
3.
Baker JR and Gatesman TJ (1985). Use of carfentanil and ketamine-xylazine mixture to immobilize wild grey seals (Halichoerus grypus). Vet. Rec . 116: 208.
4.
Balkwill F., Osborne R., Burke F., Naylor S., Talbot D., Durbin H., Avernier J., and Fries W. (1987). Evidence for tumor necrosis factor/cachectin production in cancer. Lancet1: 1229-1230.
5.
Boyd MR (1980). Biochemical mechanisms in chemical-induced lung injury: Role of metabolic activation. CRC Crit. Rev. Toxicol . 7: 103-176.
6.
Brett J., Gerlach H., Nawroth P., Steinberg S., Goodman G., and Stem D. (1989). Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G protein . J. Exp. Med. 169: 1977-1991.
7.
Carruthers SG , Nelson M., Wexler HR, and Stiller CR (1979). Xylazine hydrochloride (Rompun) overdose in man. Clin. Toxicol . 15: 281-285.
8.
Clark KW and Hall LW (1969). Xylazine-A new sedative for horses and cattle . Vet. Rec. 85: 512-517.
9.
Cooper JAD , White D., and Matthay RA (1986). Drug-induced pulmonary disease, part 1: Cytotoxic drugs. Am. Rev. Resp. Dis. 133: 321-340.
10.
Cooper JAD , White D., and Matthay RA (1986). Drug-induced pulmonary disease, part 2: Noncytotoxic drugs. Am. Rev. Resp. Dis. 133: 488-505.
11.
Cottrell TS , Levine OR, Senior RM, Weiner J., Spiro D., and Fishman AP (1967). Electron microscopic alterations at the alveolar level in pulmonary edema . Circ. Res. 21: 783-797.
12.
Cunningham AL and Hurley JV (1971). Alpha-naphthyl-thiourea-induced pulmonary oedema in the rat: A topographical and electron microscope study . J. Pathol. 106: 25-35.
13.
Cuturi MC, Murphy M., Costa-Giomi MP, Weinmann R., Perussia B., and Trinchieri G. (1987). Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral lymphocytes. J. Exp. Med. 165: 1581-1594.
14.
Decker T. and Lohmann-Matthes ML (1988). A quick and simple method for the quantitation of lactate dehydrogenase release in measurement of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Meth. 15: 61-69.
15.
Duhm B., Maul W., Medenwald M., Patzchke K., and Wegner LA (1969). Untersuchungen mit radioaktiv markieterm BAY Va 1470 an Ratten. Berl. Muench. Tieraerzt. Wochenschr. 82: 104-109.
16.
Frank L. (1985). Oxygen toxicity in eukaryotes. In: Superoxide Dismutase VIII, LW Oberley (ed). CRC Press, Boca Raton, Florida, pp. 1-43.
17.
Fried R. (1966). Colorimetric determination of xanthine dehydrogenase by tetrazolium reduction. Anal. Biochem. 16: 427-432.
18.
Fuentes VO (1978). Sudden death in a stallion after xylazine medication . Vet. Rec. 102: 106.
19.
Fujimoto K. , Parker JC, and Kayes SG (1990). Activated eosinophils increase vascular permeability and resistance in isolated perfused rat lungs . Am. Rev. Resp. Dis. 142: 1414-1421.
20.
Gallanosa AG , Spyker DA, Shipe JR, and Morris DL (1981). Human xylazine overdose: A comparative review with clonidine, phenothiazine and tricyclic antidepressants . Clin. Toxicol. 18: 663-678.
21.
Gillespie MN , Goldblum SE, Cohen DA, and McClain CJ (1988). Interleukin 1 bioactivity in the lung of rats with monocrotaline-induced pulmonary hypertension. Proc. Soc. Exp. Biol. Med. 187: 26-32.
22.
Gillespie MN , Olson JW, Henning B., Cohen DA, McClain CJ, and Goldblum, SE (1989). Monokineinduced lung injury in rats: Similarities to monocrotaline-induced pneumotoxicity. Toxicol. Appl. Pharmacol. 98: 134-143.
23.
Goldblum SE , Henning B., Jay M., Yoneda K., and McClain CJ (1989). Tumor necrosis factor α-induced pulmonary vascular endothelial injury . Infec. Immun. 57: 1218-1226.
24.
Goldblum SE , Jay M., Yoneda K., Cohen DA, McClain C., and Gillespie MN (1987). Monokine-induced acute lung injury in rabbits. J. Appl. Physiol . 63:2093-2100.
25.
Goldblum SE and Sun WL (1990). Tumor necrosis factor-α augments pulmonary arterial trans-endothelial albumin flux in vitro. Am. J. Physiol. 258: L57-L67.
26.
Goldblum SE , Yoneda K., Cohen DA, and McClain CJ (1988). Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1β . Infec. Immun. 56: 2255-2263.
27.
Goodman JC, Robertson CS, Grossman RG, and Narayan RK (1990). Elevation of tumor necrosis factor in head injury . J. Neuroimmunol. 30: 213-217.
28.
Greene SA and Thurmon JC (1988). Xylazine-A review of its pharmacology and use in veterinary medicine. J. Vet. Pharmacol. Ther. 11: 295-313.
29.
Grosso MA, Brown JM, Viders DE, Mulvin DW, Banerjee A., Velasco SE, Repine JE, and Harken H. (1989). Xanthine-oxidase-derived oxygen radicals induce pulmonary edema via direct endothelial cell injury. J. Surg. Res. 46: 355-360.
30.
Hocking DC, Phillips PG, Ferro TJ, and Johnson A. (1990). Mechanism of pulmonary edema induced by tumor necrosis factor-α. Cir. Res. 67: 68-77.
31.
Hoidal JR (1990). The eosinophil and acute lung injury. Am. Rev. Resp. Dis. 142: 1245-1246.
32.
Horvath CJ, Ferro TJ, Jesmok G., and Malik AB (1988). Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. Proc. Natl. Acad. Sci. USA85: 9219-9223.
33.
Jacobs RF, Tabor DR, Burks AW, and Campbell GD (1989). Elevated interleukin-1 release by human alveolar macrophage during adult respiratory distress syndrome. Am. Rev. Resp. Dis. 140: 1686-1692.
34.
Jarasch ED, Bruder G., and Held HW (1986). Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol. Scand. Suppl. 548: 49-46.
35.
Jarasch ED, Grund C., Bruder G., Heid HW, Keenan TW, and Franke WW (1981). Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium. Cell25: 67-82.
36.
Kanniappan M. and Ramaswamy VM (1979). A study on the toxic effects of morphine, metamidazole and xylazine. Cheiron8: 159-163.
37.
Karnovsky MJ (1965). A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy. J. Cell. Biol.25: 137A-138A.
38.
Kaye J., Gillis S., Mizel SB, Shevach EM, Malek TR, Dinarello CA, Lachman LB, and Janeway CA (1984). Growth of cloned helper T cell line induced by monoclonal antibody specific for the antigen receptor: Interleukin-1 is required for the expression of receptors for interleukin-2. J. Immunol . 133: 1339-1345.
39.
Kirkpatrick RM (1978). Use of xylazine and ketamine as a combination anesthetic. Canine Prac. 5:53-57.
40.
Kokkola K. and Valta R. (1974). Aetiology and findings in eosinophilic pleural effusion. Scand. J. Resp. Dis. Suppl. 89: 159-165.
41.
Kommonen B. and Koskien L. (1984). Fluorescein angiography of the canine ocular fundus in ketamine-xylazine anesthesia. Acta Vet. Sacnd. 25: 346-351.
42.
Korzeniewski C. and Callewaert DM (1983). An enzyme-release assay for natural cytotoxicity. J. Immunol. Meth. 64: 313-320.
43.
Levine B., Kalman J., Mayer L., Fillit HM, and Packer M. (1990). Elevated circulating levels of tumor necrosis factor in sever chronic heart failure. N. Engl. J. Med. 323: 236-241.
44.
Marano MA, Fong Y., Moldawer LL, Wei, Calvano SE, Tracey KJ, Barie PS, Manogue K., Cerami A., Shires GT, and Lowry SF (1990). Serum cachectin/ tumor necrosis factor in critically ill patients with bums correlates with infection and mortality. Surg. Obst. Gynecol.170: 32-38.
45.
Maury CPJ and Teppo AM (1987). Raised serum levels of cachectin/tumor necrosis factor α in renal allograft rejection. J. Exp. Med. 166: 1132-1137.
46.
McClain CJ, Cohen D., Ott L., Dinarello CD, and Young B. (1987). Ventricular fluid interleukin-1 activity in patient with head injury. J. Lab. Clin. Med. 110:48-54.
47.
McDonald RJ , Berger EM, and Repine JE (1987). Neutrophil-derived oxygen metabolites stimulate thromboxane release, pulmonary artery pressure increases, and weight gain in isolated perfused rat lungs . Am. Rev. Resp. Dis. 135: 957-959.
48.
Muto Y., Nouri-Aria KT, Meager A., Alexander GJ, Eddelston Alwf, and Williams R. (1988). Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet2: 72-74.
49.
National Institutes of Health ( 1985). Guide for the Care and Use of Laboratory Animals. NIH, Bethesda, Maryland.
50.
Newey RM (1977). Death of a dehorned charolais. Vet. Rec. 101: 335-336.
51.
Nolpo KB and Ryan US (1990). Enhancement of tumor necrosis factor-induced endothelial cell injury by cycloheximide. Am. J. Physiol. 259: L123-L129.
52.
Palmore WP (1990). A fatal response to xylazine and ketamine in group of rabbits. Vet. Res. Comm. 14: 91-98.
53.
Patterson CE , Barnard JW, Lafuze JE, Hull MT, Baldwin SJ, and Rhodes RA (1989). The role of activation of neutrophils and microvascular pressure in acute pulmonary edema. Am. Rev. Resp. Dis. 140: 1052-1062.
54.
Poklis A., Mackell MA, and Case ES (1985). Xylazine in human tissue and fluid in a case of fatal drug abuse. J. Anal. Toxicol. 9: 234-236.
55.
Repine JE, Bowman M., and Tate RM (1982). Neutrophils and lung edema. Chest81: 47S-50S.
56.
Roten R., Markert M., Feihl F., Schaller M., Tagan M., and Perret C. (1991). Plasma levels of tumor necrosis factor in adult respiratory distress syndrome. Am. Rev. Resp. Dis. 143: 590-592.
57.
Rowen JL, Hyde DM, and McDonald RJ (1990). Eosinophils cause acute edematous injury in isolated rat lungs. Am. Rev. Resp. Dis. 142: 215-220.
58.
Royall JA, Berkow RL, Beckman JS, Cunningham MK, Matalon S, and Freeman B (1989). Tumor necrosis factor and interleukin 1β increase vascular endothelial permeability . Am. J. Physiol. 257: L399-L410.
59.
Schuger L., Varani J., Marks RM, Kunkel SL, Johnson KJ, and Ward PA (1989). Cytotoxicity of tumor necrosis factor-α for human umbilical vein endothelial cells. Lab. Invest. 61: 62-68.
60.
Shinjo K., Tsuda S., Hayami T., Asahl T., and Kawaharada H. (1989). Increase in permeability of human endothelial cell monolayer by recombinant lymphotoxin. Biochem. Biophys. Res. Commun. 162: 1431-1437.
61.
Spoerke DG, Hall AH, Grimes MJ, Honea BN, and Rumack BH (1986). Human overdose with the veterinary tranquilizer xylazine. Am. J. Emerg. Med. 4: 222-224.
62.
Stephens KE , Ishizaka A., Larrick JW, and Raffin TA (1988). Tumor necrosis factor causes increased pulmonary permeability and edema. Am. Rev. Resp. Dis. 137:1364-1370.
63.
Stephens KE , Ishizaka A., Wu Z., Larrick JW, and Raffin TA (1988). Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs. Am. Rev. Resp. Dis. 138: 1300-1307.
64.
Uggla A. and Lindqvist A. (1983). Acute pulmonary oedema as an adverse reaction to the use of xylazine in sheep. Vet. Rec. 111, 42.
65.
Veress JF, Koss LG, and Schreiber K. (1979). Eosinophilic pleural effusions. Acta Cytol. 23: 40-44.
66.
Wilmot RW, Kassab JT, Kilian PL, Benjamin WR, Douglas SD, and Wood RE (1990). Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am. Rev. Resp. Dis. 142: 365-368.
67.
Zweier JL, Kuppusamy P., and Lutty GA (1988). Measurement of endothelial cell free radical generation: Evidence for a central mechanism of free radical injury in postischemic tissues . Proc. Natl. Acad. Sci. USA85: 4046-4050.
